Trastuzumab Deruxtecan Alone or in Combination With Anastrozole for the Treatment of Early Stage HER2 Low, Hormone Receptor Positive Breast Cancer

NCT04553770 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

88

Enrollment

OTHER

Sponsor class

Conditions

Early-stage Breast Cancer
Hormone Receptor Positive Breast Carcinoma
Invasive Breast Cancer
Stage II Breast Cancer
Stage IIA Breast Cancer
Stage IIB Breast Cancer
Stage III Breast Cancer

Interventions

DRUG: Anastrozole
PROCEDURE: Therapeutic Conventional Surgery
BIOLOGICAL: Trastuzumab Deruxtecan

Sponsor

Jonsson Comprehensive Cancer Center

Collaborators

[object Object]
[object Object]